These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10731116)

  • 21. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
    Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
    Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pivotal trials of letrozole: a new aromatase inhibitor.
    Smith IE
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):41-4. PubMed ID: 9556791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anastrozole--a new generation in aromatase inhibition: clinical pharmacology.
    Dowsett M; Lønning PE
    Oncology; 1997; 54 Suppl 2():11-4. PubMed ID: 9394854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aromatase inhibitors].
    Feutrie ML; Bonneterre J
    Bull Cancer; 1999 Oct; 86(10):821-7. PubMed ID: 10572233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letrozole in breast cancer.
    Shahab N
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
    [No Abstract]   [Full Text] [Related]  

  • 26. Aromatase inhibitors and their use in the sequential setting.
    Coombes RC; Harper-Wynne C; Dowsett M
    Endocr Relat Cancer; 1999 Jun; 6(2):259-63. PubMed ID: 10731118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New breast cancer drug.
    Brink S
    US News World Rep; 2001 Dec; 131(26):52. PubMed ID: 11793594
    [No Abstract]   [Full Text] [Related]  

  • 28. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I; Itoh T; Chen S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatase inhibitors and their application in breast cancer treatment*.
    Brodie AM; Njar VC
    Steroids; 2000 Apr; 65(4):171-9. PubMed ID: 10713305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aromatase inhibitors: past, present and future in breast cancer therapy.
    Dutta U; Pant K
    Med Oncol; 2008; 25(2):113-24. PubMed ID: 17973095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients.
    Trunet PF; Bhatnagar AS; Chaudri HA; Hornberger U
    Acta Oncol; 1996; 35 Suppl 5():15-8. PubMed ID: 9142959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study.
    Geisler J; Haynes B; Anker G; Dowsett M; Lønning PE
    J Clin Oncol; 2002 Feb; 20(3):751-7. PubMed ID: 11821457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
    Howell A; Howell SJ; Clarke R; Anderson E
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):227-37. PubMed ID: 11850229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer.
    Ingle JN; Suman VJ; Jordan VC; Dowsett M
    Endocr Relat Cancer; 1999 Jun; 6(2):265-9. PubMed ID: 10731119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endocrine therapy of causation: role of aromatase inhibitors in breast cancer].
    Longo F; Mansueto G
    Tumori; 2003; 89(6):21-8. PubMed ID: 14870836
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical use of aromatase inhibitors in the treatment of breast cancers.
    Manni A
    J Cell Biochem Suppl; 1993; 17G():242-6. PubMed ID: 8007705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letrozole. A review of its use in postmenopausal women with advanced breast cancer.
    Lamb HM; Adkins JC
    Drugs; 1998 Dec; 56(6):1125-40. PubMed ID: 9878997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anastrozole: a selective aromatase inhibitor for the treatment of breast cancer.
    Higa GM; alKhouri N
    Am J Health Syst Pharm; 1998 Mar; 55(5):445-52. PubMed ID: 9522927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are differences in the available aromatase inhibitors and inactivators significant?
    Johnson PE; Buzdar A
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4360s-4368s; discussion 4411s-4412s. PubMed ID: 11916226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
    Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP
    J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.